Factors Influencing the Release of Cholecystokinin Induced by Gastrin-Releasing Peptide in Man

References

• Fried G M, Ogden W D, Greeley G, Thompson J C. Correlation of release and actions of cholecystokinin in dogs before and after vagotomy. Surgery 1983; 93: 786–791
   PubMed Web of Science ®Google Scholar
• Himeno S, Tarui S, Kanayama T, Kurokawa N, et al. Plasma cholecystokinin response after digestion of liquid meal and intraduodenal infusion of fat, amino acids, or hydrochloric acid in man: an analysis with region specific radioimmunoassay. Am J Gastroenterol 1983; 78: 703–707
   PubMed Web of Science ®Google Scholar
• Liddle R A, Green G M, Conrad C K, Williams J A. Proteins but not aminoacids, carbohydrates or fats stimulate cholecystokinin secretion in the rat. Am J Physiol 1986; 251: G243–G248
   PubMed Web of Science ®Google Scholar
• Liddle R A, Goldfine I D, Williams J A. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor and alcohol. Gastroenterology 1984; 87: 542–549
   PubMed Web of Science ®Google Scholar
• Owyang C, Louie D S, Tatum D. Feedback regulation of pancreatic enzyme secretion: suppression of cholecystokinin release by trypsin. J Clin Invest 1986; 77: 2042–2047
   PubMed Web of Science ®Google Scholar
• Iwai K, Fukuoha S I, Fushiki T, Tsujikawa M, et al. Purification and sequencing of a trypsin-sensitive cholecystokinin-releasing peptide from the rat pancreatic juice. J Biol Chem 1987; 262: 8956–8959
   PubMed Web of Science ®Google Scholar
• Maton P N, Selden A C, Chadwick P S. Atropine inhibits meal stimulated release of cholecystokinin. Scand J Gastroenterol 1984; 19: 831–834
   PubMed Web of Science ®Google Scholar
• Guzman S, Shayvialle J A, Banks W A, Rayford P L, Thompson J C. Effect of vagal stimulation of pancreatic secretion and on blood levels of gastrin, cholecystokinin, secretin, vasoactive intestinal peptide, and somatostatin. Surgery 1979; 86: 329–336
   PubMed Web of Science ®Google Scholar
• Schafmayer A, Luestede R, Pompino A, Köhler H. Vagal influence on cholecystokinin and on neurotensin release in conscious dogs. Scand J Gastroenterol 1988; 23: 315–320
   PubMed Web of Science ®Google Scholar
• Lundell L, Lindstedt G, Olbe L. Origin of gastrin liberated by gastrin releasing peptide in man. Gut 1987; 28: 1128–1133
   PubMed Web of Science ®Google Scholar
• Wood S M, Yong R T, Webster J D, et al. The effect of the mamillian neuropeptide, gastrin releasing peptide (GRP) on gastrointestinal and pancreatic hormone secretion in man. Clin Scin 1983; 65: 365–371
   Web of Science ®Google Scholar
• Jansen J BMJ, Lamers C BHW. Effect on bombesin and plasma cholecystokinin in normal persons and gastroectomized patients measured by sequence specific radioimmunoassay. Surgery 1984; 96: 55–60
   PubMed Web of Science ®Google Scholar
• Forssell H, Stenqvist B, Lundell L, Olbe L. A criterion for completeness of vagotomy based on basal and vagal stimulated gastric acid secretion after esophagectomy or proximal gastric vagotomy. Scand J Gastroenterol 1988; 23: 534–538
   PubMed Web of Science ®Google Scholar
• Cantor P, Rehfeld J F. The molecular nature of cholecystokinin in human plasma. Clin Chim Acta 1987; 168: 153–158
   PubMed Web of Science ®Google Scholar
• Cantor P, Rehfeld J F. Cholecystokinin in pig plasma: release of components devoid of a bioactive COOH-terminus. Am J Physiol 1989; 256: G53–G61
   PubMed Web of Science ®Google Scholar
• Cantor P. Evaluation of a radioimmunoassay for cholecystokinin in human plasma. Scand J Clin Lab Invest 1986; 46: 213–221
   PubMed Web of Science ®Google Scholar
• Rehfeld J H. Immunochemical studies on cholecystokinin. I. Development of sequence-specific radioimmunoassays for porcine triacontatria peptide cholecystokinin. J Biol Chem 1978; 252: 4016–4021
   Google Scholar
• Rehfeld J F, Hoist J J, Lindkaer Jensen S. The molecular nature of vascularly released cholecystokinin from the isolated perfused porcine duodenum. Regul Pept 1982; 3: 15–28
   PubMedGoogle Scholar
• Schneeman B O, Lyman R L. Distribution of cholecystokinin activity in the rat small intestine. Digestion 1977; 15: 28–33
   PubMed Web of Science ®Google Scholar
• Sjölund K, Sandén G, Håkanson R, Sundler F. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 1983; 85: 1120–1130
   PubMed Web of Science ®Google Scholar
• Greeley G H, Burdett J B, Hill F LC, Spannagel A, Trowbridge J, Thompson J C. Distribution of cholecystokinin in the human alimentary canal. Gastroenterology 1984; 86: A1097
   Web of Science ®Google Scholar
• Eysselein V E, Reeve J R, Jr, Eberlein G. Cholecystokinin-gene structure, and molecular forms in tissue and blood. Z Gastroenterol 1986; 24: 645–659
   PubMed Web of Science ®Google Scholar
• Reeve JR, Jr, Eysselein V E, Walsh J H, Bcn-Awram C M, Shively J E. New molecular forms of cholecystokinin; microsequence analysis of forms previously characterized by chromatographic methods. J Biol Chem 1986; 261: 16392–16397
   PubMed Web of Science ®Google Scholar
• Eberlein G A, Eysselein V E, Goebell H. Chole-cystokinin-58 is the major molecular form in man, dog and cat but not in the pig, beef and rat intestine. Peptides 1988; 9: 993–998
   PubMed Web of Science ®Google Scholar
• Eysselein V E, Eberlein G A, Schaeffer M, et al. Characterization of the major form of cholecystokinin in human intestine: CCK-58. Am J Physiol 1990; 258: G253–G260
   PubMed Web of Science ®Google Scholar
• Larsson L, Rehfeld J F. Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system. Brain Res 1979; 282: 407–410
   Google Scholar
• Leander S, Ekman R, Uddman R, Sandler F, Hakanson R. Neuronal cholecystokinin, gastrin releasing peptide, neurotensin and beta-endorphin in the intestine of the guinea pig. Cell Tissue Res 1984; 235: 521–531
   PubMed Web of Science ®Google Scholar
• Hutchinson J B, Dimaline R, Dockray G J. Neuropeptides in the gut: Quantification and characterization of cholecystokinin octa peptide-bombesin and vasoactive intestinal polypeptide-like immuno-reactivities in the myenteric plexus of the guinea pig small intestine. Peptides 1981; 2: 23–30
   PubMed Web of Science ®Google Scholar
• Dockray G J, Gregory R A, Tracy H C, Zhu W Y. Transport of cholecystokinin-octapeptide-like immunoreactivity toward the gut in afferent vagal fibers in cat and dog. J Physiol 1981; 314: 501–511
   PubMed Web of Science ®Google Scholar
• Rehfeld J F, Lundberg J M. Cholecystokinin in feline vagal and sciatic nerves: concentration, molecular form and transport velocity. Brain Res 1983; 275: 341–347
   PubMed Web of Science ®Google Scholar
• Moran T H, Smith G B, Hostetler A M, McHugh P R. Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches. Brain Res 1987; 415: 149–152
   PubMed Web of Science ®Google Scholar
• Koop H, Mönnikes H, Kopp B, Dionysius C, Schwarz C, Arnold R. Effect of the prokinetic drug Cisaprid on gastrointestinal hormone release. Scand J Gastroenterol 1986; 21: 907–913
   PubMed Web of Science ®Google Scholar
• Becker H D, Werner M, Schafmayer A. Release of radioimmunologic cholecystokinin in human subjects. Am J Surg 1984; 147: 124–129
   PubMed Web of Science ®Google Scholar
• Järhult J, Graffner H, Bloom S R. The influence of modified sham-feeding on plasma polypeptide (CCK, gastrin, motilin, neurotensin and somatostatin) concentrations in duodenal ulcer disease. Acta Chir Scand 1984; 150: 141–144
   PubMedGoogle Scholar
• Cantor P, Hoist J, Knuthsen S, Rehfeld J F. The effect of vagal stimulation on the release of cholecystokinin in anaesthetized pigs. Scand J Gastroenterol 1986; 21: 1069–1072
   PubMed Web of Science ®Google Scholar
• Hopman W PM, Jansen J BMJ, Lamers C BHW. The effect of atropine on the plasma cholecystokinin response to intraduodenal fat in man. Digestion 1984; 29: 19–25
   PubMed Web of Science ®Google Scholar
• deJong A JL, Klamer M, Jansen J BMJ, Lamers C BHW. Effect of atropine and somatostatin on bombesin stimulated plasma gastrin, cholecystokinin and pancreatic polypeptide in man. Regul Pept 1987; 17: 285–293
   PubMedGoogle Scholar
• Hopman W PM, Jansen J BMJ, Lamers C BHW. Plasma cholecystokinin response to oral fat in patients with Billroth I and Billroth II gastrectomy. Ann Surg 1984; 199: 276–280
   PubMed Web of Science ®Google Scholar
• Inoue K, Tobe T, Suzuki T, Hihosotani R, et al. Plasma cholecystokinin and pancreatic polypeptide response after radical pancreatoduodenectomy with Billroth I and Billroth II type of reconstruction. Ann Surg 1987; 206: 148–154
   PubMed Web of Science ®Google Scholar
• Inoue K, Fuchigami A, Hosotani R, Hyuang Y, et al. Release of cholecystokinin and gallbladder contraction before and after gastrectomy. Ann Surg 1987; 205: 27–32
   PubMed Web of Science ®Google Scholar
• Sjövall M, Lundell L, Rehfeld J F, Olbe L. Studies of the release of gastrin from the human duodenum induced by gastrin-releasing peptide. Scand J Gastroenterol 1989; 24: 445–453
   PubMed Web of Science ®Google Scholar
• Brodin K, Nilsson G. Increase in duodenal tissue gastrin in dogs following antrectomy with gas-troduodenostomy and after total gastrectomy with esophagoduodenostomy. Acta Physiol Scand 1982; 116: 113–120
   PubMedGoogle Scholar
• Brodin K, Nilsson G. Gastrin in duodenal and jejunal tissue and in plasma following antrectomy and gastrojejunostomy. Acta Physiol Scand 1982; 116: 153–158
   PubMedGoogle Scholar